Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients.
about
Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicansBeneficial effects of HIV peptidase inhibitors on Fonsecaea pedrosoi: promising compounds to arrest key fungal biological processes and virulenceProtease expression by microorganisms and its relevance to crucial physiological/pathological eventsA peptide derived from the highly conserved protein GAPDH is involved in tissue protection by different antifungal strategies and epithelial immunomodulation.Wild-type Drosophila melanogaster as a model host to analyze nitrogen source dependent virulence of Candida albicans.HIV aspartyl protease inhibitors as promising compounds against Candida albicans André Luis Souza dos SantosCandida albicans secreted aspartyl proteinases in virulence and pathogenesisDetection of Candida albicans in oral squamous cell carcinoma by fluorescence staining technique.Models of oral and vaginal candidiasis based on in vitro reconstituted human epitheliaCD8 T cells and E-cadherin in host responses against oropharyngeal candidiasis.Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin.Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children.Enterolobium contortisiliquum trypsin inhibitor (EcTI), a plant proteinase inhibitor, decreases in vitro cell adhesion and invasion by inhibition of Src protein-focal adhesion kinase (FAK) signaling pathways.Virulence factors and genetic variability of vaginal Candida albicans isolates from HIV-infected women in the post-highly active antiretroviral era.Chemical inhibitors of Candida albicans hyphal morphogenesis target endocytosis.Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells.Inhibitory activity of human immunodeficiency virus aspartyl protease inhibitors against Encephalitozoon intestinalis evaluated by cell culture-quantitative PCR assayTetracycline-inducible expression of individual secreted aspartic proteases in Candida albicans allows isoenzyme-specific inhibitor screening.Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.Secreted aspartyl proteinase (PbSap) contributes to the virulence of Paracoccidioides brasiliensis infection
P2860
Q28082407-341F0C62-B119-4E75-9ED5-BB6CCB72F86BQ28473767-FB8C670C-C6DC-4EBB-8E56-C5A72EEF6D81Q28477918-64E5DC36-AC61-4387-A638-C7C6A863F55EQ29871450-8F2F6736-AE90-4405-A869-FF94726AEA5DQ34081541-29B50CD0-2DC5-400E-8BEC-86C4489B1075Q34878614-59CC3113-C0E6-4FD7-A405-7A0227977A45Q35215948-B413A909-7932-4FCC-B7CF-D960145D2302Q35292662-51E678A8-1500-4832-BE16-1AC7281F77B0Q35629661-F5FB3CB2-88A0-42FB-BAAE-67762C7950C4Q35656077-2462F185-9B13-4950-91DE-60B431CFBB29Q35920633-D2B0BA6F-6D2D-48AC-ACAE-95A0CCEF302BQ37286930-3FC4C9AD-1ED5-44E4-98D1-D6FCFE90A3A8Q37379784-1C7C771A-FCB9-42E0-B2C3-0598D27316A6Q39450541-2E69A54C-68F3-4F0A-A2D5-4EC80314CDFEQ40100260-EE985775-436B-44F0-A04A-4C0D6B6D60BCQ40129265-D5F81187-1077-4467-950A-BB61643BA111Q40138652-B804FAAC-04B4-40DA-9E18-B1714D68B141Q40417013-831F27DA-882C-452E-B07B-BBC4DD6E3A29Q41768949-A19C7FE5-03F4-4110-8A33-94E8EBA9924EQ44792128-AACE924D-2E3E-4ED6-B26B-6790DD15B6ECQ59127572-FC1C113E-6C05-4ED2-BFDE-C0259678BC4A
P2860
Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Effects of the human immunodef ...... es from HIV-infected patients.
@en
Effects of the human immunodeficiency virus
@nl
type
label
Effects of the human immunodef ...... es from HIV-infected patients.
@en
Effects of the human immunodeficiency virus
@nl
prefLabel
Effects of the human immunodef ...... es from HIV-infected patients.
@en
Effects of the human immunodeficiency virus
@nl
P2093
P2860
P356
P1476
Effects of the human immunodef ...... tes from HIV-infected patients
@en
P2093
P2860
P304
P356
10.1128/AAC.43.8.2038
P407
P577
1999-08-01T00:00:00Z